6 days ago
Innogen Pharma Said to Take Orders This Week for Hong Kong IPO
Guangzhou Innogen Pharmaceutical Group Co. plans to take investor orders as soon as this week for its initial public offering in Hong Kong, people familiar with the matter said.
The diabetes and metabolic diseases-focused biopharmaceutical company aims to raise as much as $100 million in the share sale, the people said, asking not to be identified discussing a private matter.
